Skip to main content
Ping Chi, MD, Oncology, New York, NY

PingChiMDPhD

Oncology • New York, NY

Hematologic Oncology, Melanoma, Sarcoma

Member and Attending Physician, Memorial Sloan-Kettering Cancer Center.

Request Appointment

Overview of Dr. Chi

Dr. Ping Chi is an oncologist in New York, NY and is affiliated with Memorial Sloan Kettering Cancer Center. She received her medical degree from Weill Cornell Medicine and has been in practice 14 years. Dr. Chi accepts several types of health insurance, listed below. She is one of 503 doctors at Memorial Sloan Kettering Cancer Center who specialize in Oncology. She has more than 90 publications and over 500 citings.

Education & Training

  • Memorial Sloan Kettering Cancer Center
    Memorial Sloan Kettering Cancer CenterFellowship, Hematology and Medical Oncology, 2005 - 2010
  • Brigham and Women's Hospital
    Brigham and Women's HospitalResidency, Internal Medicine, 2003 - 2005
  • Weill Cornell Medicine
    Weill Cornell MedicineClass of 2003

Certifications & Licensure

  • FL State Medical License
    FL State Medical License 2021 - Present
  • NY State Medical License
    NY State Medical License 2004 - 2026
  • NJ State Medical License
    NJ State Medical License 2019 - 2025
  • NC State Medical License
    NC State Medical License 2020 - 2022
  • Medical Oncology
    American Board of Internal Medicine Medical Oncology

Clinical Trials

Publications & Presentations

PubMed

Press Mentions

  • Researchers Look for New Ways to Attack Resistant Cancers
    Researchers Look for New Ways to Attack Resistant CancersNovember 14th, 2024

Grant Support

  • Harnessing double stranded-RNA (dsRNA)-response and anti-tumor effect in PRC2-inactivated cancerSLOAN-KETTERING INST CAN RESEARCH2023–2028
  • Clinical Scholars Biomedical Research Training ProgramSLOAN-KETTERING INST CAN RESEARCH1985–2028
  • Clinical Scholars Biomedical Research Training ProgramSLOAN-KETTERING INST CAN RESEARCH1985–2028
  • Clinical Scholars Biomedical Research Training ProgramSLOAN-KETTERING INST CAN RESEARCH1985–2028
  • Phase II Study of ASTX727 in Patients with PRC2 loss Malignant Peripheral Nerve Sheath Tumor (MPNST)SLOAN-KETTERING INST CAN RESEARCH2022–2027
  • Phase II Study of ASTX727 in Patients with PRC2 loss Malignant Peripheral Nerve Sheath Tumor (MPNST)SLOAN-KETTERING INST CAN RESEARCH2022–2027
  • Phase II Study of ASTX727 in Patients with PRC2 loss Malignant Peripheral Nerve Sheath Tumor (MPNST)SLOAN-KETTERING INST CAN RESEARCH2022–2027
  • Phase II Study of ASTX727 in Patients with PRC2 loss Malignant Peripheral Nerve Sheath Tumor (MPNST)SLOAN-KETTERING INST CAN RESEARCH2022–2026
  • Phase II Study of ASTX727 in Patients with PRC2 loss Malignant Peripheral Nerve Sheath Tumor (MPNST)SLOAN-KETTERING INST CAN RESEARCH2022–2026
  • Phase II Study of ASTX727 in Patients with PRC2 loss Malignant Peripheral Nerve Sheath Tumor (MPNST)SLOAN-KETTERING INST CAN RESEARCH2022–2026
  • Understanding and targeting MAPK pathway activation in NF1-deficient malignant peripheral nerve sheath tumor (MPNST)SLOAN-KETTERING INST CAN RESEARCH2021–2026

Insurance Accepted

  • Aetna Choice POS II
    Aetna HMO
    Anthem Blue Access PPO
    Anthem Blue Preferred HMO
    Anthem Blue Preferred Plus POS
    BCBS Blue Card PPO
    BCBS Illinois PPO
    BCBS Texas BlueChoice
    CIGNA HMO
    CIGNA Open Access
    CIGNA PPO
    Empire BCBS HMO
    Empire BCBS PPO
    First Health PPO
    Great West PPO
    Humana ChoiceCare Network PPO
    Multiplan PHCS PPO
    Multiplan PPO
    MVP Healthcare PPO
    Oxford Health Freedom
    Oxford Health Liberty
    United Healthcare - Direct Choice Plus POS
    United Healthcare - Direct Options PPO
    WEA Trust POS-SE
    WEA Trust Preferred Provider Plan - Trust Pref
  • Please verify your coverage with the provider's office directly when scheduling an appointment

Dr. Ping Chi, Dr. Ping Chi, MD, Dr. P Chi